USFDA approval granted for this BP lowering drug

The tentative USFDA approval applies to 40mg and 80mg dosages of Azilsartan Medoxomil tablets.

94
USFDA Drug product Approval
USFDA Approval

Last Updated on July 12, 2024 by The Health Master

USFDA approval

Leading Indian pharmaceutical company Zydus Lifesciences has secured a significant victory, receiving tentative USFDA approval from the U.S. Food and Drug Administration (USFDA) to market its generic Azilsartan Medoxomil tablets.

This medication is a crucial tool in the fight against hypertension (high blood pressure), a major public health concern.

Expanding Patient Access to Affordable Treatment

The tentative USFDA approval applies to 40mg and 80mg dosages of Azilsartan Medoxomil tablets.

This generic version offers a more cost-effective option for patients struggling with high blood pressure, potentially increasing access to this vital medication.

Zydus Lifesciences will manufacture the tablets at their state-of-the-art facility in Ahmedabad SEZ – II, India.

Combating Cardiovascular Risks

Azilsartan Medoxomil functions as an angiotensin II receptor blocker (ARB).

By working in this way, the medication helps to lower blood pressure, thereby reducing the risk of serious cardiovascular events, including:

  • Stroke
  • Myocardial infarction (heart attack)

Flexible Treatment Options

This USFDA approval highlights the versatility of Azilsartan Medoxomil tablets.

This medication can be prescribed alone or in combination with other antihypertensive drugs, tailoring treatment plans to individual patient needs.

A Promising Future for Azilsartan Medoxomil

Zydus Lifesciences’ achievement is a major step forward in providing patients with effective and affordable blood pressure management solutions.

With a projected USD 89 million market size in the United States (IQVIA MAT March 2024), Azilsartan Medoxomil tablets have the potential to make a significant impact on public health.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news